Introduction
Prenatal cocaine exposure (PCE) is considered a marker for potential development of neurobehavioral problems soon after delivery and during childhood/adolescence. [1] [2] [3] The harmful effects of intrauterine cocaine exposure are not restricted to mental illness. Changes in the cardiovascular system have been reported in studies using animal models. 4 In humans, changes have been observed in the neuroendocrine system and metabolic processes, with increased weight gain and childhood obesity. 5, 6 Taken together, these data suggest a hypothesis that cocaine exposure can have systemic effects. Notwithstanding, the pathways underlying these systemic effects in exposed newborns remain uncertain. One possible explanation that is consistent with other conditions [7] [8] [9] [10] [11] [12] [13] [14] is early activation of the inflammatory response.
Studies using neurobiological markers have suggested that cocaine dependence is a chronic stress state. 15 For example, Fox et al. 16 compared 28 adults with cocaine dependence to 27 social drinkers and demonstrated an elevated inflammatory state, as measured by interleukin-10 (IL-10), among other factors. Another report found higher levels of IL-1β, TNF-α, and IL-10 in the circulation of 53 male crack/cocaine addicts than in 50 controls. 17 Cocaine and its metabolites readily cross the placenta, reaching fetal tissues at high concentrations 18, 19 and deregulating fetal homeostasis. A study of the effects of PCE on infant hypothalamic-pituitary-adrenal (HPA) axis activity and reactivity at 7 months of infant age revealed that exposed infants had a high amplitude trajectory of cortisol reactivity compared to non-cocaineexposed infants. 20 Sustained stress triggers a series of changes in cytokines. Chronic stress leads to activation of the HPA axis, sympathetic nervous system axis, and vagus fibers, provoking secretion of glucocorticoids, catecholamines, and acetylcholine, thereby disturbing cytokine homeostasis. 14 
It is difficult to distinguish which effects during child
and adolescent development might be due to PCE and which may be due to other adverse conditions. Cocaineexposed infants are at higher levels of environmental risk and experience unstable caregiving. 21 This highlights the importance of identifying neurobiological markers closer in time to intrauterine exposure. Studies focusing specifically on crack/cocaine -or cocaine -exposure and cytokines in newborns are scarce. Only one study exists, but cytokine levels were not its primary outcome measure and the sample size was small (five exposed infants and five controls). 22 It is known that the neonatal immune system is immature relative to the adult immune system. 23 Specifically, anti-inflammatory Th2 response predominates, which is probably a consequence of the gestational immunosuppression that is necessary to maintain the fetus without it being rejected as a foreign body. 24 There is also a relative absence of IL-12 production until the end of infancy, favoring Th2 response. 23 During pregnancy, a dynamic and delicate balance between inflammatory and anti-inflammatory cytokines is expected, to protect growth and development of both fetus and placenta. 24 Given the close relationship between cocaine exposure and inflammatory response, the objective of this study is to evaluate markers of inflammation (IL-6 and IL-10) in newborns with a history of crack/ cocaine exposure in utero (exposed newborns, EN) and to compare them with non-exposed newborns (NEN), measuring these markers in umbilical cord blood (UCB).
This strategy makes it possible to identify biomarkers very early in the neurodevelopment process, before exposure to other external adverse conditions has occurred. The hypothesis is that greater activation of the inflammatory response will be observed in the newborns with a history of crack/cocaine exposure in utero. A secondary objective is to evaluate the same markers in the mothers of these newborns during the postpartum period.
Materials and methods
Data were collected at the Hospital de Clínicas de Porto Alegre (HCPA) and the Hospital Materno Infantil Presidente Vargas (HMIPV), both in the city of Porto Alegre, Brazil, from January 2012 to September 2013.
Both facilities are teaching hospitals as well as centers of excellence for high-risk pregnancies. All mothers provided written informed consent for participation, and the project was approved by the Research Ethics
Committees of both hospitals.
Study design and sample
This was a cross-sectional study. The factor under study was history of intrauterine exposure to crack/ cocaine and the outcome measures were serum levels of the cytokines interleukin (IL)-6 and IL-10 in UCB.
A secondary outcome was measurement of the same markers assayed in the serum of these newborns' mothers.
Mother/newborn dyads with a history of crack/ cocaine exposure underwent consecutive sampling at HMIPV. Mothers were questioned about use of substances of abuse at admittance to the hospital. 
Instruments and variables
The independent variable was a history of crack/ cocaine use during pregnancy. Potential confounders were: maternal intelligence quotient (IQ), maternal psychopathology, use of other psychoactive substances, and demographic and perinatal data. Maternal IQ was estimated using the cube and vocabulary subtests of the Screening Test (ASSIST), 29 as previously used by our group. 30 By taking these measures, we were able to evaluate substance use in the 3 months prior to delivery. 
Results
The sample comprised 57 newborns with a history of prenatal crack/cocaine exposure and 99 with no history of exposure. 
Main outcome variable: IL levels in UCB
In the GLM analyses for IL-6, results were adjusted for intensity of alcohol, tobacco, and cannabis use in the last There were no correlations between IL-6 and IL-10 levels in maternal serum or in UCB plasma (all p ≥ 0.28;
Spearman correlation), whether for inter-group or intragroup comparisons. However, there was a significant marital status, and other sociodemographic variables were systematically collected using a standard form.
Ethnicity was dichotomized as non-white or white. The following neonatal variables were obtained by review of medical records: weight, 1 and 5 minute Apgar scores, GA at neonatal examination, sex, need for hospitalization, and GA classification. Data on mothers' clinical status (syphilis, HIV, and/or hepatitis C), mode of delivery, and prenatal care were also collected from medical records.
The outcome measures level of IL-6 and level of IL-10 in UCB and maternal blood were collected and assayed as described below.
Blood collection and processing
Total blood (10 mL) samples were collected by venipuncture into an anticoagulant-free vacuum tube.
Immediately after collection, blood samples were centrifuged at 4000 rpm/min for 10 min and serum (from patients and controls) or plasma (from newborns) was aliquoted, labeled, and stored at -80 °C until the time of testing.
Cytokine measurement
Cytokine concentrations were determined via flow cytometry using the BD™ Cytometric Bead Array 
Statistical analysis
Normally distributed categorical and quantitative variables were analyzed with the chi-square test and Student's t test for independent samples respectively.
When distribution was not normal, the Mann-Whitney U test was used instead and values were expressed as medians and ranges. The main outcome measure was 
Secondary outcome measures: maternal IL levels in the immediate postpartum period
According to GLM analysis, using a model including intensity of alcohol and tobacco use in the last 3 months before delivery, mode of delivery, and maternal ethnicity, interquartile range = 597.13-3,017.68; n = 24; p = 0.022).
Although the median IL-10 level was also higher in newborn boys with a history of crack/cocaine exposure in utero than 
Discussion
This study analyzed early neurobiological markers involved in inflammatory activation in newborns with a history of crack/cocaine exposure in utero. These markers were measured at delivery, when the newborn
has not yet been exposed to other stressors. We found a significant increase in inflammatory activation in newborns with a history of intrauterine crack/ cocaine exposure, as assessed both by IL-6 and IL-10 measures; and this finding remained after adjusting for confounders. In pregnant women who reported crack/ cocaine use, inflammatory activation (measured by IL-6) was also observed, considering confounders. Among the exposed newborns, male newborns seemed particularly vulnerable to inflammatory activation. Arriving at an explanation for our findings is complex and may involve a variety of mechanisms that interact with each other.
Other studies have evaluated peripheral inflammatory markers in cocaine users, and have found a trend toward greater inflammatory activation. 16, 17 However, studies specifically investigating mother/newborn dyads exposed to crack/cocaine are scarce, limiting the scope for comparison of our findings. Cocaine may be linked with inflammation resulting from the neuronal damage or death that it causes. 17 In terms of neuronal death, crack/cocaine would be more hazardous than snorted cocaine because of the byproducts of pyrolysis, which generates anhydroecgonine methyl ester. for generations to come. 40, [47] [48] [49] Knowing that exposure to cocaine alters corticostriatal gene expression, 50 which also changes the stress response, we can expect these newborns to develop a more active warning system, leaving them vulnerable to addictive behavior. Although we did not assess cerebral morphology, studies have suggested an inverse association between IL-6 levels and hippocampal volume. 51, 52 These changes in the hippocampus may contribute to the cognitive deficits observed in infants, toddlers, and children exposed to cocaine in utero. [53] [54] [55] [56] [57] In an animal model, gestational cocaine exposure induced significant changes to the electrophysiological properties of hippocampal neurons. 58 Intrauterine exposure to crack/cocaine could leave an immunological scar, making these infants vulnerable to physical and/or psychiatric disorders throughout life.
This study helps to elucidate neurobiological mechanisms underlying these phenomena and contributes research topics of interest for future interventions. So far no evidence has been found to support treatments directed at the immune system from the psychiatric point of view. However, minocycline has been reported to reduce inflammatory activation in schizophrenic adults 59 and agents that target inflammatory processes are being considered for the treatment of depression.
60-62
The present study has certain limitations. We used two measures to assess deregulation of the immune system (IL-10 and IL-6), but other markers are available.
However, much research on neuroinflammation has been based on changes in IL-6 and IL-10. [63] [64] [65] [66] Our sample comprised pregnant polydrug users. This increases the external validity of the study and, the data were adjusted for use of other substances in multivariate analysis. However, because of the size of the sample, the study does not have enough power to isolate all the factors that could influence inflammation response.
Additionally, information about drug use was collected by retrospective interview, and is therefore subject to recall bias. We could not evaluate many of the crack/ cocaine using women at delivery time (lost to the 40, 41 It is to be expected that pregnant women who use crack/cocaine will exhibit different responses in comparison with their newborns, because of the accumulation of stressors to which they are exposed throughout the course of their lives, coupled with the need to adapt to these factors. Our study, for example, detected several other chronic stressors (some prior to pregnancy)
in those who reported crack/cocaine use when compared to controls (Table 1) . Our findings agree with previous studies reporting that gestational stress is associated with greater inflammatory activation, [42] [43] [44] which places newborns in a more vulnerable position, either because of the intensity of activation or because of changes in IL-6 and IL-10 levels. Furthermore, boys with a history of crack/cocaine exposure in utero were significantly more likely to exhibit increased IL levels than girls. This finding is also in agreement with other studies. 45, 46 Thus, this study may contribute to the search for neurobiological markers of the future clinical and/ or neuropsychiatric repercussions of intrauterine crack/cocaine exposure demonstrated in previous research. 1, 3 These types of clinical changes, which persist into adulthood, have been understood through women who received, for instance, zero or incomplete prenatal care. Finally, since this is a cross-sectional study, it cannot be used to establish causal relationships.
Conclusion
This study found elevated markers of inflammatory activation in the UCB of newborns with a history of crack/cocaine exposure in utero and in peripheral blood samples from their mothers when compared to nonexposed controls. These changes can be regarded as neurobiological markers, which represent a link between neurodevelopmental and clinical changes. Confirmation of these findings in future studies could be used to support preventive intervention strategies that target the immune system of the newborn, perhaps improving prognosis as a result.
